News
Serious safety concerns around unlicensed ocular bevacizumab use versus...
 Recently announced results from two-year CATT (Comparison of Age-related macular degeneration Treatment Trials) adds to the growing body of evidence, including CATT 1-year data...
News
AstraZeneca to acquire Ardea Biosciences for $1 billion
AstraZeneca and Ardea Biosciences, Inc. have entered into a definitive merger agreement, pursuant to which AstraZeneca will acquire Ardea, a San Diego, California-based biotechnology company...
News
Key protein responsible for controlling nerve cell protection
A key protein, which may be activated to protect nerve cells from damage during heart failure or epileptic seizure, has been found to regulate...
News
Rosetta wins European patent covering core element of microRNA...
Rosetta Genomics has won a European patent covering the use of miR-34a in the preparation of pharmaceuticals used to treat p53-negative cancers. ...
News
Women don’t receive the same treatment as men for...
Women with acute coronary syndrome (ACS) receive inferior or less aggressive treatment compared to men, according to three large studies presented today at the...
News
Advances in personalized medicine for lung cancer
 Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented...
News
Abbott reports positive levodopa-carbidopa intestinal gel study data
Abbott has announced the Phase 3 study results of its levodopa-carbidopa intestinal gel (LCIG), used for the treatment of advanced Parkinson's Disease (PD). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.